Paul Talks Science

Paul ADEPOJU, PhD
  • ٠٫٠ (٠)
  • العلوم
  • مرتان في الأسبوع

Welcome to "Paul Talks Science," a podcast that journeys into the ever-evolving realms of health, science, and innovation. Hosted by Paul Adepoju, each episode features thought-provoking conversations with experts and trailblazers who are shaping the future of medicine and technology. From groundbreaking research to revolutionary treatments, "Paul Talks Science" delves deep into the stories and ideas that will define tomorrow's world. Join us as we explore the cutting edge, challenge the status quo, and uncover the innovations that hold the promise of a better, healthier future.

  1. Building Cancer Systems that Work

    قبل ٥ أيام

    Building Cancer Systems that Work

    Season 3 kicks off with Professor Richard Sullivan (King’s College London) on why cancer outcomes depend less on shiny tech and more on end-to-end systems that actually work. We dig into affordability, widening inequalities, and why “reality-stratified” care beats one-size-fits-all blueprints. Richard unpacks adaptive HTA and health-benefit packages, the limits of screening without treatment pathways, the UK’s own pressure points, and what equitable cancer control looks like in rural, fragile, and conflict settings. We also talk financing—domestic resource mobilisation, the role of multilateral development banks, and why political commitment matters more than headlines. Host: Paul Adepoju Guest: Prof Richard Sullivan, Director, Institute of Cancer Policy, King’s College London Companion read: Paul’s feature from this interview in The Lancet Oncology: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00591-1/abstract If you enjoy the show, follow, rate, and share “Paul Talks Science.” New episodes every Monday.

    ٤٧ من الدقائق

  2. ١٨ أغسطس

    Resistance, Regulation, and Reformulation: Malaria’s Next Scientific Chapter

    In this episode of Paul Talks Science, Paul Adepoju sits down with Adam Aspinall, Senior Director of Access & Product Management at Medicines for Malaria Venture (MMV). They discuss the science and strategy behind a groundbreaking new malaria drug for newborns and young children — the first of its kind. From how scientists reformulated existing treatments to meet the needs of infants, to the global regulatory pathways that made rapid approval possible, this conversation sheds light on the innovation, policy, and persistence shaping the future of malaria control.

    ٢١ من الدقائق
  3. HIV Treatment and the Realities of Growing Older

    ٢٨ يوليو

    HIV Treatment and the Realities of Growing Older

    As people living with HIV live longer, a new challenge emerges: how do we adapt treatment for an ageing population? In this episode of Paul Talks Science, Paul Adepoju speaks with Dr Loice Achieng Ombajo of the Department of Clinical Medicine and Therapeutics at the University of Nairobi, about research shaping the future of HIV care for older adults. Drawing on findings from two studies, Dr Ombajo explores the shift from three-drug to two-drug regimens, the growing burden of comorbidities such as kidney disease, diabetes and cancer, and the implications of long-term antiretroviral use. The conversation also tackles why older adults are often overlooked in HIV research, the policy changes needed to protect this rapidly growing group, and what decades of treatment tell us about sustaining health into older age. From funding cuts to the promise of long-acting therapies, this episode examines what it really means to maintain the gains of the HIV response as populations age.

    ٢٠ من الدقائق

  4. ٧ يوليو

    How Economics Drives Safer Chemistry

    In this special episode of Paul Talks Science—the first in a series recorded during my visit to the Toxics Use Reduction Institute (TURI) at the University of Massachusetts Lowell—I sit down with TURI Director Baskut Tuncak to unpack how economics is playing a pivotal role in driving safer chemical practices. We explore the Institute's origins, the real-world impact of the Toxics Use Reduction Act, and how businesses are shifting away from hazardous substances—not because they're forced to, but because it makes economic sense. Baskut also reflects on his global work as a UN Special Rapporteur and explains why TURI’s locally rooted, solution-focused model could be a blueprint for change far beyond Massachusetts.

    ٢٣ من الدقائق

  5. ٣٠ يونيو

    Oxitec’s Mosquitoes and the Promise of Malaria Control

    In this episode, Paul spotlights Oxitec — the biotech company behind one of the most ambitious malaria control projects on the African continent. CEO Grey Frandsen joins Paul Talks Science to break down how Oxitec’s genetically modified mosquitoes are being deployed in Djibouti to target Anopheles stephensi, an invasive urban mosquito driving malaria resurgence in cities. They discuss how the technology works, why Djibouti is leading the way, and what it takes to scale lab-bred solutions into real-world impact. It's a story of science, strategy — and the promise of fighting malaria with mosquitoes. 🧬 For the full story, read Paul’s feature in Nature Medicine: Battle of the Mosquitoes

    ٣٦ من الدقائق
  6. Battle of the Mosquitoes

    ٢٢ يونيو

    Battle of the Mosquitoes

    What if the future of malaria control involves releasing more mosquitoes — not fewer? In this special feature episode, science journalist Paul Adepoju takes you deep into the high-stakes fight against a new urban malaria threat: Anopheles stephensi. From the labs of British biotech firm Oxitec to the malaria-stricken streets of Djibouti, and with insight from top global health experts like Dr. William Moss of Johns Hopkins, this narrative journey unpacks how genetically modified mosquitoes are being deployed to stop one of humanity’s oldest diseases. You’ll hear directly from: Colonel Abdoulilah Ahmed Abdi, leading malaria control efforts in Djibouti Grey Frandsen, CEO of Oxitec Neil Morrison, Oxitec’s Chief Strategy Officer Dr. William Moss, malaria researcher and public health expert This episode is based on Paul’s feature story for Nature Medicine. For the full deep-dive, read “Battle of the Mosquitoes” on Nature Medicine online. 🎙️ Science. Public health. Innovation. Genes versus disease — this is Paul Talks Science.

    ١٦ من الدقائق

  7. ١٦ يونيو

    What Genomics Reveals About Mpox

    Mpox is surging again across parts of Africa — and this time, it seems like the world is paying even less attention. In this episode, I sit down with Ifeanyi Omah, a Wellcome Trust Doctoral Researcher in Hosts, Pathogens, and Global Health at the University of Edinburgh, to unpack the science behind the current outbreak. We discuss the evolving mpox landscape, including what genomic data is telling us (and what it isn’t), how human behavior and viral mutations intersect, why Sierra Leone has become a hotspot, and why building Africa’s capacity for outbreak response remains critical. 🎧 This conversation complements my new Lancet article — “Sierra Leone struggles as mpox surges across Africa.” 👉 Read it here: thelancet.com/article/PIIS0140-6736(25)01242-5/fulltext

    ٣١ من الدقائق

  8. ٢ يونيو

    The Politics of a Scan: Making Imaging a Global Priority

    In this episode of Paul Talks Science, I spoke with Prof. Hedvig Hricak, lead commissioner of The Lancet Oncology Commission on Medical Imaging and Nuclear Medicine, to discuss a historic win for global health: the newly adopted resolution at the 78th World Health Assembly that prioritizes access to medical imaging across low- and middle-income countries. We talk about how this resolution came to be, what it means for cancer and non-communicable disease care, and how innovations in artificial intelligence and affordable imaging technologies are reshaping the landscape. Prof. Hricak also reflects on the power of collaboration between professional societies, governments, and global health institutions — and why political will is finally catching up to medical reality. This conversation builds on my reporting for The Lancet Oncology. You can read the full article here:📖 Cancer took centre stage at the World Health Assembly Whether you're a policymaker, health professional, or global health advocate, this episode offers insight into how imaging access could shift the future of care — and why this resolution may be the start of something transformational.

    ٢١ من الدقائق
مشاهدة الكل (٤٣)

حول

Welcome to "Paul Talks Science," a podcast that journeys into the ever-evolving realms of health, science, and innovation. Hosted by Paul Adepoju, each episode features thought-provoking conversations with experts and trailblazers who are shaping the future of medicine and technology. From groundbreaking research to revolutionary treatments, "Paul Talks Science" delves deep into the stories and ideas that will define tomorrow's world. Join us as we explore the cutting edge, challenge the status quo, and uncover the innovations that hold the promise of a better, healthier future.

المعلومات

  • صناع العمل
    Paul ADEPOJU, PhD
  • سنوات النشاط
    ٢٠٢٤ - ٢٠٢٥
  • الحلقات
    ٤٣
  • التقييم
    ملائم
  • حقوق النشر
    © Paul ADEPOJU, PhD
  • موقع البرنامج على الويب
    Paul Talks Science